Analyst stock forecast
UroGen Pharma Forecast: $60.00 Analyst Target
URGN has a $60.00 target, Strong Buy rating and 8 analysts. As of 2026-08-23.
Direct answer
UroGen Pharma's average price target is $60.00.
The target implies +28% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +2.4%, the high target implies +60.1%, and the range spans 57.6% of the current price.
Forecast evidence checked August 23, 2026.
Get free UroGen Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $46.86
- Average price target
- $60.00
- High price target
- $75.00
- Low price target
- $48.00
- Low target gap
- +2.4%
- Target upside
- +28%
- High target gap
- +60.1%
- Target range width
- 57.6%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 23, 2026
- Valid through
- August 30, 2026
Explore related company data
Read the frequently asked questions.
What is UroGen Pharma's average price target?
UroGen Pharma's verified average price target is $60.00. The target range is $48.00 to $75.00.
How far are UroGen Pharma's low and high targets from the recorded price?
The low target implies +2.4%, while the high target implies +60.1%.
How many analysts are included in UroGen Pharma's consensus?
The verified consensus includes 8 analysts.
How is UroGen Pharma's target upside or downside calculated?
The average target of $60.00 is divided by the recorded price of $46.86, then one is subtracted to produce +28%. This does not guarantee a future return.
When was UroGen Pharma's analyst forecast verified?
The data was verified on 2026-08-23. The dataset is valid through 2026-08-30.